<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p96" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_96{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_96{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_96{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_96{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_96{left:128px;bottom:1042px;letter-spacing:0.16px;}
#t6_96{left:238px;bottom:1042px;letter-spacing:-0.19px;}
#t7_96{left:238px;bottom:1020px;letter-spacing:-0.01px;}
#t8_96{left:238px;bottom:1001px;letter-spacing:-0.01px;}
#t9_96{left:238px;bottom:981px;letter-spacing:-0.01px;}
#ta_96{left:238px;bottom:962px;letter-spacing:-0.01px;}
#tb_96{left:238px;bottom:942px;letter-spacing:-0.01px;}
#tc_96{left:238px;bottom:923px;letter-spacing:-0.01px;}
#td_96{left:238px;bottom:904px;letter-spacing:-0.01px;}
#te_96{left:238px;bottom:884px;letter-spacing:-0.01px;}
#tf_96{left:238px;bottom:865px;letter-spacing:-0.01px;}
#tg_96{left:238px;bottom:791px;letter-spacing:-0.01px;}
#th_96{left:238px;bottom:772px;letter-spacing:-0.01px;}
#ti_96{left:238px;bottom:752px;letter-spacing:-0.01px;}
#tj_96{left:238px;bottom:733px;letter-spacing:-0.01px;}
#tk_96{left:238px;bottom:698px;letter-spacing:-0.01px;}
#tl_96{left:238px;bottom:679px;letter-spacing:-0.01px;}
#tm_96{left:238px;bottom:659px;letter-spacing:-0.01px;}
#tn_96{left:238px;bottom:640px;letter-spacing:-0.01px;}
#to_96{left:238px;bottom:620px;letter-spacing:-0.01px;}
#tp_96{left:293px;bottom:571px;}
#tq_96{left:321px;bottom:572px;letter-spacing:-0.01px;}
#tr_96{left:293px;bottom:542px;}
#ts_96{left:321px;bottom:543px;letter-spacing:-0.01px;}
#tt_96{left:293px;bottom:513px;}
#tu_96{left:321px;bottom:513px;letter-spacing:-0.01px;}
#tv_96{left:293px;bottom:484px;}
#tw_96{left:321px;bottom:484px;letter-spacing:-0.01px;}
#tx_96{left:293px;bottom:455px;}
#ty_96{left:321px;bottom:455px;letter-spacing:-0.01px;}
#tz_96{left:293px;bottom:426px;}
#t10_96{left:321px;bottom:426px;letter-spacing:-0.01px;}
#t11_96{left:293px;bottom:397px;}
#t12_96{left:321px;bottom:397px;letter-spacing:-0.01px;}
#t13_96{left:388px;bottom:368px;}
#t14_96{left:388px;bottom:339px;}
#t15_96{left:388px;bottom:311px;}
#t16_96{left:388px;bottom:282px;}
#t17_96{left:388px;bottom:254px;}
#t18_96{left:416px;bottom:368px;letter-spacing:-0.01px;}
#t19_96{left:416px;bottom:340px;letter-spacing:-0.01px;}
#t1a_96{left:416px;bottom:311px;letter-spacing:-0.01px;}
#t1b_96{left:416px;bottom:283px;letter-spacing:-0.01px;}
#t1c_96{left:416px;bottom:255px;letter-spacing:0.21px;}
#t1d_96{left:238px;bottom:225px;letter-spacing:-0.01px;}
#t1e_96{left:238px;bottom:206px;letter-spacing:-0.01px;}
#t1f_96{left:238px;bottom:187px;letter-spacing:-0.01px;}
#t1g_96{left:238px;bottom:167px;letter-spacing:-0.01px;}
#t1h_96{left:238px;bottom:148px;letter-spacing:-0.01px;}
#t1i_96{left:238px;bottom:128px;letter-spacing:-0.01px;}
#t1j_96{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_96{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_96{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_96{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_96{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_96{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts96" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg96Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg96" style="-webkit-user-select: none;"><object width="908" height="1286" data="96/96.svg" type="image/svg+xml" id="pdf96" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_96" class="t s0_96">7.9. Supportive therapy </span><span id="t2_96" class="t s1_96">96 </span>
<span id="t3_96" class="t s2_96">Radiotherapy showed no significant difference between the two treatment </span>
<span id="t4_96" class="t s2_96">modalities [339]. </span>
<span id="t5_96" class="t s3_96">7.9. </span><span id="t6_96" class="t s3_96">Supportive therapy </span>
<span id="t7_96" class="t s2_96">In the case of laryngeal carcinoma, the various treatment options interact with each other and </span>
<span id="t8_96" class="t s2_96">with many different normal tissues. Potential side effects (organ loss due to surgery, fibrosis </span>
<span id="t9_96" class="t s2_96">after radiotherapy) influence the treatment - in the primary decision, the combinability and the </span>
<span id="ta_96" class="t s2_96">prognosis. Prevention, treatment and support in the management of treatment consequences </span>
<span id="tb_96" class="t s2_96">have a significant impact on the quality of life of patients with and after laryngeal carcinoma. </span>
<span id="tc_96" class="t s2_96">For this reason, side effects are also discussed in various parts of the other chapters of this </span>
<span id="td_96" class="t s2_96">guideline. This chapter deals with the prophylaxis and treatment of individual side effects of </span>
<span id="te_96" class="t s2_96">treatment for laryngeal carcinoma, and general supportive measures, which are to be </span>
<span id="tf_96" class="t s2_96">understood in the broader sense as supportive therapy. </span>
<span id="tg_96" class="t s2_96">In principle, a distinction must be made between side effects that occur during and </span>
<span id="th_96" class="t s2_96">immediately after therapy and those that either occur immediately and are long-lasting or </span>
<span id="ti_96" class="t s2_96">occur over a longer period after therapy - the latter are particularly observed after </span>
<span id="tj_96" class="t s2_96">radiotherapy. </span>
<span id="tk_96" class="t s2_96">At this point, reference is made to the S3 guideline on supportive measures in oncology, the </span>
<span id="tl_96" class="t s2_96">first version of which was published in October 2016. Many specific side effects are described in </span>
<span id="tm_96" class="t s2_96">detail there and presented with recommendations. In order to avoid overlapping updates, the </span>
<span id="tn_96" class="t s2_96">following side effects of radiotherapy and chemotherapy will not be commented on here, even </span>
<span id="to_96" class="t s2_96">if they are relevant: </span>
<span id="tp_96" class="t s4_96">• </span><span id="tq_96" class="t s2_96">Anemia / Neutropenia </span>
<span id="tr_96" class="t s4_96">• </span><span id="ts_96" class="t s2_96">Nausea/Emesis </span>
<span id="tt_96" class="t s4_96">• </span><span id="tu_96" class="t s2_96">Diarrhea </span>
<span id="tv_96" class="t s4_96">• </span><span id="tw_96" class="t s2_96">Oral mucositis due to chemotherapy </span>
<span id="tx_96" class="t s4_96">• </span><span id="ty_96" class="t s2_96">Tumor therapy-induced skin toxicity </span>
<span id="tz_96" class="t s4_96">• </span><span id="t10_96" class="t s2_96">Chemotherapy-induced neurotoxicity (CIPN) </span>
<span id="t11_96" class="t s4_96">• </span><span id="t12_96" class="t s2_96">Supportive therapy in radiation oncology </span>
<span id="t13_96" class="t s4_96">O </span>
<span id="t14_96" class="t s4_96">O </span>
<span id="t15_96" class="t s4_96">O </span>
<span id="t16_96" class="t s4_96">O </span>
<span id="t17_96" class="t s4_96">O </span>
<span id="t18_96" class="t s2_96">Radiodermatitis </span>
<span id="t19_96" class="t s2_96">Radiation osteonecrosis </span>
<span id="t1a_96" class="t s2_96">Radiogenic mucositis </span>
<span id="t1b_96" class="t s2_96">Radiogenic xerostomia </span>
<span id="t1c_96" class="t s0_96">Effects of radiation on the brain and spinal cord </span>
<span id="t1d_96" class="t s2_96">The diagnosis of laryngeal cancer is shocking for most patients and can change their life plans </span>
<span id="t1e_96" class="t s2_96">in one fell swoop. After the shock of the cancer diagnosis and the explanation of the expected </span>
<span id="t1f_96" class="t s2_96">therapy including further post-operative treatments, the patient must process the explanation </span>
<span id="t1g_96" class="t s2_96">of the possible changes in voice formation, breathing, facio-oral functions (smell, blowing) and </span>
<span id="t1h_96" class="t s2_96">stigmatizing changes in the throat area (stoma). It is therefore important to offer the patient </span>
<span id="t1i_96" class="t s2_96">rehabilitation and </span>
<span id="t1j_96" class="t s0_96">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
